Tissum raises 38.75 mln euros

Tissum said Nov. 20 that it raised 38.75 million euros ($42.78 million) in a series B round of funding. New investors include BNP Paribas Développement, the European Investment Fund (EIF), M&L Investments, ValQuest Partners, while TISSIUM’s returning investors were Bpifrance, CM-CIC Innovation, Cap Décisif Management, Omnes Capital and Sofinnova Partners. Tissium, of Paris, is life sciences company aiming to develop and commercialize a biopolymer platform to address various unmet clinical needs.

North AmericaUSHealthcareBriefs